First Line Metastatic Breast Cancer Treatment (ESMERALDA)
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Metastatic Breast Cancer
Interventions: DRUG: Eribulin
Sponsor: ARCAGY/ GINECO GROUP